Health Press Release – Newsletter for February 4, 2011

Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs

MADRID, February 3, 2011 – Digna Biotech and the Centro de Investigaci??n M??dica Aplicada (CIMA) de
la Universidad de Navarra announced today that the European Union (EU) has
finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and
CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million
respectively for the clinical …. Original article on Gaea Times at  : Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs.

Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test

Partnership Expected to Expand Molecular Test Offering in Developing Country Markets

SUNNYVALE, California and GENEVA, February 3, 2011 – Cepheid (Nasdaq: CPHD) and FIND (Foundation for Innovative New
Diagnostics) today announced a new collaboration to accelerate the
development of a rapid molecular test for the measurement of human
immunodeficiency virus (HIV) viral load.
The Xpert(R) …. Source article on Gaea Times at  : Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test.

Spinning for the Upper Body From Virgin Active Health Clubs

Health Club Chain Launches Kranking(R), the Brand New Upper Body Workout From Spinning Creator Jonny G

LONDON, February 3, 2011 – Virgin Active Health Clubs (www.virginactive.co.uk/) is
launching the latest US exercise trend, Kranking(R), into all 71 of its
health clubs nationwide following successful trials in West London and
Sheffield. Innovated by spinning guru, Jonny G, Kranking(R) aims … Read more »»».